Clinical Performance of CEAT

Remote analysis of treatment achievement of metastatic lung tumors

Of the total 207 cases of lung cancer treated at our clinic, 72.9% (151 cases) suffered from metastatic lung tumors (metastasized to lung from the primary lesion).  Many of them have been diagnosed as metastatic lung tumors with unknown primary origin, of which the primary lesion could not be identified and for which treatment had to be interrupted.  These patients often had no other choice than to visit our clinic.  The result of a remote survey of all lung cancer cases treated with cancer energy annihilation therapy (CEAT) showed a one-year survival rate of 58.8%, and    a two-year survival rate of 39.5%.  The survival rate was stabilized at 22% even after the fourth year, and none of the patients who survived for four years or longer relapsed.
     In CEAT, the primary lesion is detected by resonance response test, and microwaves are then irradiated on multiple carcinomata in the body.  Microwave therapy is effective in cylindrical areas of several centimeters in diameter at multiple regions. This feature makes it possible to treat cancers of which the primary lesion cannot be identified in conventional medicine.
     Generally, metastatic lung tumors are of a progressive and developmental type, so the survival rate of these cases is low when compared to that of primary lung cancer cases.  In this sense, the survival rate of metastatic lung cancer cases treated with cancer energy annihilation therapy is deemed significantly higher in comparison with that for cases treated with conventional methods.